INFORMATION ABOUT THE ISSUER 5 5.2 INVESTMENTS 5.2.1 HISTORICAL INVESTMENTS Our historical investments since 2015 involve mainly the acquisition of property, plant and equipment, and intangible assets. The following table sets forth our net cash used in investing activities for the relevant periods: As of December 31, 2016 2017 K€ K€ Cash flows from investment activities Acquisitions of property, plant and equipment (188) (236) Acquisitions of intangible assets (1) – Acquisitions of non-current financial assets 8 (232) Acquisition of current financial assets – (216) Sales of property, plant and equipment 11 – Purchase of short-term investments – – Net cash flows from investment activities (170) (684) Over the course of the period presented, our investments the types of investments that we make and our investments primarily consisted of investments in our offices, lease deposit for objectives will be similar in nature to investments made during the our subsidiary located in the United States of America, equipment, 2016 to 2017 period. However, investment expenditures can be installations and furniture. uneven and unpredictable, particularly when they are associated with external growth transactions. 5.2.2 ONGOING INVESTMENTS We currently expect that the amount of our cash expenditures 5.2.3 FUTURE PLANNED INVESTMENTS for investment in 2018 will be generally consistent with the level As of the date of this Registration Document, we do not have any of investment during the 2016 to 2017 period. We expect that material commitments to make investments in the future. GENSIGHT BIOLOGICS – 2017 Registration Document– 63